Response Biomedical hires Tim Shannon as senior VP, adds Jonathan Wang to board of directors
Response Biomedical Corp.
Kinetic Concepts names Mike Mathews global senior VP | Personnel Moves
Kinetic Concepts names new global senior VP
San Antonio, Texas-based wound care devices maker Kinetic Concepts named Mike Mathews its new global senior vice president.
MassDevice.com +3 | The top 3 med-tech stories for May 21, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Response Biomedical launches internal review of products sold to “terrorist” countries
Response Biomedical (TSE:RBM) launched an internal audit of its exports to restricted companies in response to a Securities & Exchange Commission inquiry into sales to countries deemed "state sponsors of terrorism."
Accuray slides on lowered sales outlook | Earnings Roundup
Accuray (NSDQ:ARAY) shares are down nearly 10% today as investors react to wider 3rd-quarter losses and a lower sales forecast for the rest of fiscal 2012.
The Sunnyvale, Calif.-based radiosurgery device maker reported losses of $14.9 million, or 21¢ per share, on sales of $101.8 million during the 3 months ended March 31.
Smith & Nephew shareholder faction opposes CEO Bohuon’s $2.5M “golden hello” | Personnel Roundup
A significant chunk of Smith & Nephew‘s (FTSE:SN; NYSE:SNN) shareholders withheld their endorsement or voted outright against a $2.5 million "golden hello" for new CEO Olivier Bohuon after an advisory board recommended a veto.
World Heart’s 2011 sales go negative | Earnings roundup
Boston Scientific CFO Jeffrey Capello joins board of OvaScience | Personnel Moves
Boston Scientific (NYSE:BSX) executive vice president and chief financial officer Jeffrey Capello joined the board of directors at OvaScience, a Boston, Mass.-based start up developing infertility treatments.
Capello began working at Boston Scientific in 2008, landing the CFO seat in 2010. He oversees the company’s global finance, information systems, business development and corporate strategy functions.
Bovie swings to 2011 black | Earnings Roundup
Diabetes: GE invests in non-invasive continuous glucose monitors | Funding Roundup
GE Healthcare (NYSE: GE) invested an undisclosed amount into C8 Medisensors, a developer of non-invasive continuous glucose monitors for diabetic patients.
C8 aims to provide glucose monitoring that is "painless, accurate, continuous, noninvasive, and nonintrusive to your life," according to its website.
The San Jose, Calif.-based company’s glucose monitors use light spectroscopy to measure blood glucose levels without the need for frequent finger pricks.
